Application Sponsors
Marketing Status
Prescription | 001 |
Prescription | 002 |
Prescription | 003 |
Prescription | 004 |
Application Products
001 | TABLET, EXTENDED RELEASE;ORAL | 1.5MG | 0 | PALIPERIDONE | PALIPERIDONE |
002 | TABLET, EXTENDED RELEASE;ORAL | 3MG | 0 | PALIPERIDONE | PALIPERIDONE |
003 | TABLET, EXTENDED RELEASE;ORAL | 6MG | 0 | PALIPERIDONE | PALIPERIDONE |
004 | TABLET, EXTENDED RELEASE;ORAL | 9MG | 0 | PALIPERIDONE | PALIPERIDONE |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2022-06-29 | STANDARD |
Submissions Property Types
TE Codes
001 | Prescription | AB |
002 | Prescription | AB |
003 | Prescription | AB |
004 | Prescription | AB |
CDER Filings
LUPIN LTD
cder:Array
(
[0] => Array
(
[ApplNo] => 208643
[companyName] => LUPIN LTD
[docInserts] => ["",""]
[products] => [{"drugName":"PALIPERIDONE","activeIngredients":"PALIPERIDONE","strength":"1.5MG","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"PALIPERIDONE","activeIngredients":"PALIPERIDONE","strength":"3MG","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"PALIPERIDONE","activeIngredients":"PALIPERIDONE","strength":"6MG","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"PALIPERIDONE","activeIngredients":"PALIPERIDONE","strength":"9MG","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"06\/29\/2022","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2022-06-29
)
)